


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+9.18%
+3.61%
+16.15%
-3.87%
ADCT
ADC Therapeutics SA
$4.88
Strengths

Upgraded on attractively valued
ADCT Price Performance
$3.91 (+24.81%)
$4.23 (+15.37%)
$4.26 (+14.55%)
$1.41 (+246.10%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
ADCT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ADCT Street Sentiment is extremely bullish and have negative views on the near-term outlook
ADCT has Medium risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Dec 29, 2025
Upgrade
Buy
Zacks
Nov 18, 2025
Upgrade
Buy
Zacks
Oct 16, 2025
Reiterate
Buy
HC Wainwright & Co.
What is ADCT current stock price?
What are ADCT stock strengths?
What is ADCT Risk Level?
What is ADCT market cap and volume?
What is ADCT current Stock IQ?
Should I buy ADCT stock right now?
Is ADCT a Strong Buy right now?
What does a 'Strong Buy' rating mean for ADCT?
What does a 'Strong Sell' rating mean for ADCT?
What factors influence ADCT's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
ADCT
ADC Therapeutics SA
Current Price
$4.88

ADCT Price Performance
$3.91 (+24.81%)
$4.23 (+15.37%)
$4.26 (+14.55%)
$1.41 (+246.10%)
ADCT Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
ADCT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ADCT Street Sentiment is extremely bullish and have negative views on the near-term outlook
ADCT has Medium risk level
Risk Indicators
Overall Wall Street Rating
ADCT Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued
ADCT Latest Analysis
ADC Therapeutics Narrows Losses Supported By Higher Product Revenue And Ongoing Restructuring . (RTTNews) - ADC Therapeutics SA (ADCT) has reported its fourth quarter and full-year 2025 financial results showing improved net loss figures compared with the prior year as the company continues to streamline operations and advance its ZYNLONTA clinical programs.
Tue Mar 10, 2026
ADC Therapeutics Non-GAAP EPS of -$0.05 revenue of $23.06M beats by $0.77M.
Tue Mar 10, 2026
What to Expect from ADC Therapeuticss Earnings. ADC Therapeutics (NYSE:ADCT) is gearing up to announce its quarterly earnings on Tuesday 2026-03-10. Here'.s a quick overview of what investors should know before the release.Analysts are estimating that ADC Therapeutics will report an earnings per share (EPS) of $-0.29.Anticipation surrounds ADC Therapeutics'.s announcement with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.Ne
Mon Mar 9, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ADCT Stock trends
ADCT Stock performance
ADCT Stock analysis
ADCT investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.